PF-07832837

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07832837, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients [Phase 1]